Protracted COVID-19 during Treatment of Facial Palsy

Mehrdad Hasibi; Maral Seyed Ahadi; Hamed Abdollahi; Mehrdad Jafari

doi:10.1155/2021/5569841

Protracted COVID-19 during Treatment of Facial Palsy

Case Rep Neurol Med. 2021 Jun 4:2021:5569841. doi: 10.1155/2021/5569841. eCollection 2021.

Authors

Mehrdad Hasibi¹, Maral Seyed Ahadi², Hamed Abdollahi³, Mehrdad Jafari⁴

Affiliations

¹ Professor of Infectious Diseases, Amiralam Hospital, Tehran University of Medical Sciences, South Saadi St., Tehran, Iran.
² Assistant Professor of Neurology, Amiralam Hospita, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, South Saadi St., Tehran, Iran.
³ Assistant Professor, Department of Anesthesiology, Amiralam Hospital, Tehran University of Medical Sciences, South Saadi St., Tehran, Iran.
⁴ Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Valiasr hospital, Baqerkhan St., Tehran, Iran.

Abstract

Neurologic manifestations are increasingly reported as the coronavirus disease 2019 (COVID-19) pandemic continues. This is a report of a COVID-19 patient with Bell's palsy. Case Summary. A 52-year-old man with fever and malaise was tested positive for COVID-19. After a week, he developed right-sided peripheral facial palsy and was treated with corticosteroids in conjunction with antiviral treatment which resulted in complete recovery. Discussion. Concomitant treatment of corticosteroids and antiviral treatment can decrease morbidity in patients with COVID-19-related Bell's palsy.

Publication types

Case Reports